Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

Researchers identified 4 prepregnancy conditions that were associated with better pregnancy outcomes among patients with SLE.

Pericarditis recurrence in lupus is more likely — and has a dose-dependent relationship — with oral prednisone treatment, ...

Lupus Alert Day serves a vital purpose. It encourages others to learn more about lupus, share information on social media, ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Charles River Laboratories International, Inc. CRL and Valo Health, Inc. recently announced an advanced product candidate for the treatment of different forms of lupus and other autoimmune indications ...

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage ...

Systemic lupus erythematosus (SLE) is a chronic, complex autoimmune disorder characterized by a diverse spectrum of clinical manifestations. Although survival rates among patients with SLE have ...

A common form of lupus is systemic lupus erythematosus. Systemic lupus erythematosus affects the whole body and can attack virtually any part of it, including skin, major organs, hair, muscles ...

CLE may occur in association with systemic lupus erythematosus (SLE). The most common subtypes are discoid (DLE) and subacute (SCLE), accounting for 80% and 16% of cases, respectively. Both TYK2 ...

The company reported positive phase 2 data from the cohort of cutaneous lupus erythematosus (CLE) patients late last year. Thursday, Merck revealed the systemic lupus erythematosus (SLE ...